VIENNA, Austria and RIJSWIJK, The Netherlands, Oct. 19, 2016 /PRNewswire/ -- Today Lexogen, a transcriptomics and next generation sequencing company, announces collaboration with Bluebee, a leading provider of high-performance genomics solutions, for implementation of QuantSeq data analysis pipeline on the Bluebee genomics analysis platform.
Lexogen's QuantSeq 3' mRNA-Seq Library Prep Kit has already been recognized as one of the fastest, most cost-efficient, and accurate methods for expression profiling using next generation sequencing. It is also the most preferable alternative to microarrays for this application. The data analysis for QuantSeq is based on counting of the transcripts and therefore is very straightforward and fast.
By making the QuantSeq analysis pipeline available on the Bluebee genomics analysis platform the data evaluation can be easily done by any user, including those who do not have any experience with bioinformatics tools. This makes QauntSeq an exceptional tool for gene expression analysis, which is accurate, fast, affordable, and bioinformatically not challenging. "We believe that implementing a ready-to-use data analysis pipeline on the Bluebee platform is an important step forward in making QuantSeq the most easy-to-use and cost-efficient gene expression profiling workflow available," said Dr. Alexander Seitz, CEO and founder of Lexogen.
At the American Society of Human Genetics (ASHG) meeting 2016 in Vancouver Lexogen and Bluebee will present the result of collaboration during several demonstrations at the Bluebee exhibition booth.
About Lexogen
Lexogen is a transcriptomics and next generation sequencing company, focusing on the development of technologies for complete transcriptome sequencing. Its portfolio includes innovative molecular biology kits, software, and services for RNA-Seq.
To learn more, visit www.lexogen.com and follow @lexogen.
Contact person at Lexogen:
Dalia Daujotyte
dalia.daujotyte@lexogen.com
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna
Austria
About Bluebee
Bluebee (www.bluebee.com) provides high performance genomics solutions, enabling genomic labs to substantially reduce cost and time-to-diagnosis. Bluebee's unique cloud-based accelerated genomics platform enables fast, efficient and affordable processing of large volumes of genomics data. With Bluebee's private-cloud based solutions, labs can run their pipelines orders of magnitude faster without compromising the algorithms and methods used, nor the flexibility required to provide quality, sensitivity and reliability.
Contact person at Bluebee:
Valerie Morel
valerie.morel@bluebee.com
Bluebee
Laan van Zuid Hoorn 57
2289 DC Rijswijk
The Netherlands
SOURCE Lexogen